F

Freeline

293 employees

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Haemophilia
Gene Therapy
Fabry
Purpose
Gaucher
Innovation
Health Care
AAV
Therapeutics
Medical
Life changing
Biopharma
Life Science

Date founded

2015

Funding rounds raised

Total raised

$116M

from 10 investors over 10 rounds

F

Freeline raised $26M on March 10, 2022

Investors: Syncona Limited

F

Freeline raised $80M on June 30, 2020

Investors: Acorn Bioventures, Wellington Management, Eventide Asset Management and Novo Holdings

F

Freeline raised $40M on December 19, 2019

Investors: Syncona Limited

F

Freeline raised undisclosed on May 24, 2019

Investors: Innovate UK

F

Freeline raised $116M on June 20, 2018

Investors: UCL Technology Fund and Syncona Limited

F

Freeline raised $1.5M on June 22, 2016

Investors: UCL Technology Fund

FAQ